Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CLBS stock: Caladrius Biosciences Inc

Current Rating
Sell

Previous Rating

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$4.16
Market Cap
33.1M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
0.6
P/S
3.14
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-
FCF
-
Op. Margin
-
Net Margin
162.00%
ROE
58.90%
ROI
-278.50%
ROA
27.30%
EPS Growth
117.60%
Current Ratio
1.2
Debt/Equity
55.10%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
American Renal Associates Hold (ARA) $18.66 - - 556.5M Strong Buy
Endo International PLC (ENDP) $8.01 - - 1.75B Strong Buy
Nature's Sunshine Prod. (NATR) $12.05 - 3.50% 219.3M Strong Buy
Encision Inc (ECIA) $0.38 - - 4.9M Strong Buy
ImmunoGen, Inc. (IMGN) $7.92 - - 1.03B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More